Skip to main content

3-MeO-PCP Facts

Dissociative; Arylcyclohexylamine; NMDA receptor antagonist

Description

3-MeO-PCP (3-methoxyphencyclidine) is a synthetic dissociative of the arylcyclohexylamine class. It blocks glutamate signaling in the brain, producing disconnection from body and environment alongside an unusually energized, stimulant-like quality.

Subjective effects include dissociation, stimulation, visual hallucinations, grandiosity, and cognitive disconnection. The experience differs from most dissociatives — rather than sedation and withdrawal, it produces a driven, energized quality that can escalate rapidly into mania-like disinhibition and frank psychosis.

Dependence potential has never been formally studied, and the toxic dose is unknown — multiple fatalities are documented, nearly all involving other substances.[1][2] The margin between a stimulating dissociative state and a psychiatric emergency is narrow, and amnesia during the experience prevents self-assessment of danger.[3][4]

Dose and durationby route · individual sensitivity varies

Oral(mg)
Threshold< 2 mgLight4 – 8 mgCommon8 – 15 mgStrong15 – 25 mgHeavy25+ mg

Starts in 30 – 90 minLasts 4 – 8 hoursAfter-effects 4 – 48 hours

Body and dependence

Acute toxicity
High
Chronic toxicity
Moderate
Physical dependence
Low
Psychological dependence
Moderate
Withdrawal
None recorded
Compulsive redosing
Moderate

Tolerance

Builds
Moderate
Fully resets after
10 days
Carries over to
PCP; ketamine; MXE; 3-HO-PCP; DXM; nitrous oxide

Effectslikely at a common dose

Perception
Visual drifting; +9 possible, including Spatial disorientation, Visual haze / noise
Body
Pupil dilation; +10 possible, including Excessive sweating, Dehydration sensation, Dizziness
Thinking
Confusion; +7 possible, including Compulsive redosing urge, Memory suppression
Feeling
none likely · 4 possible, including Anxiety, Mania, Paranoia
Self
Disinhibition; Depersonalization; Derealization

Who shouldn't take it

Absolute
Cardiac arrhythmia; Bipolar disorder; Pregnancy and breastfeeding
Relative
Respiratory disease; Hepatic impairment; Concurrent CYP2D6 inhibitor use

Combinations61 recorded

Lethal (5)
Benzodiazepines, Barbiturates; GHB, Baclofen; GHB, GBL; Ibogaine; Local anesthetics
Dangerous (37)
Alpha-2 adrenergic receptor antagonist; Amphetamines; Benzodiazepines; Buprenorphine, Kratom; Cannabis, THC; Ephedrine, Pseudoephedrine; Gabapentin, Pregabalin; MDMA, Amphetamines; Naltrexone; NDRIs (Wellbutrin); NRIs; NSAIDs; Opioids; Stimulants; THC; Anticholinergics; Antihistamines; Atypical antipsychotics; Buspirone; Caffeine; CBD; Clonidine, Guanfacine; Dopamine agonists; Glutamate modulator; and 13 more, see full page
Caution (16)
See full page: psychedex.org/substances/3-meo-pcp
Not graded (3)
Not listed never means safe.

Seek help immediately if

  • Severe disorientation; unable to move or speak (deep dissociation / "k-hole")
  • Complete loss of coordination — cannot stand or walk safely
  • Vomiting while incapacitated (choking / aspiration risk)
  • Very high blood pressure; fast heart rate
  • Slow or shallow breathing at high doses (especially mixed with depressants)
  • Unconsciousness; rarely, seizures

What to do

  1. Move them somewhere safe, away from stairs, water, roads, and sharp edges — they cannot protect themselves
  2. Place in the recovery position if vomiting or unconscious (aspiration is a key risk)
  3. Stay with them and reassure calmly; keep the environment quiet
  4. If breathing is slow/shallow or they are unresponsive, call emergency services
  5. Do not let them wander; do not leave them alone
  6. Be ready to give rescue breaths / CPR

Effects wear off with time in a safe, monitored setting. The main dangers are physical injury and aspiration while incapacitated, and respiratory depression when combined with other depressants — not the dissociation itself.

988 Suicide & Crisis LifelineFireside Project: 62-FIRESIDE

Version r1 · Not medical advice

References

  1. [1]
    ^Arbouche N, Kintz P, Zagdoun C, Gheddar L, Raul JS, Ameline A (2021) Determination of 3-MeO-PCP in human blood and urine in a fatal intoxication case, with a specific focus on metabolites identification — Forensic Sciences Research doi:10.1080/20961790.2021.1928821
  2. [2]
    ^Copeland CS, Hudson S, Treble R, Hamnett HJ (2022) The First Fatal Intoxication with 3-MeO-PCP in the UK and a Review of the Literature — Journal of Analytical Toxicology doi:10.1093/jat/bkac015
  3. [3]
    ^Berar A, Allain JS, Allard S, Lefevre C, Baert A, Morel I, Bouvet R, Gicquel T (2019) Intoxication with 3-MeO-PCP alone: A case report and literature review — Medicine doi:10.1097/md.0000000000018295
  4. [4]
    ^Pepe M, Di Nicola M, Cocciolillo F, Chiappini S, Martinotti G, Calcagni ML, Sani G (2024) 3-Methoxy-Phencyclidine Induced Psychotic Disorder: A Literature Review and an 18F-FDG PET/CT Case Report — Pharmaceuticals (Basel) doi:10.3390/ph17040452
Print version
Report an issue